Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/07/2022 ,inter alia, to consider and approve Pursuant to Regulation 29 and Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, 21st day of July, 2022, to transact the following business: 1) To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended on 30th June, 2022; 2) Appointment of Chintan K. Patel, Company Secretary as a Secretarial Auditor of the Company for the financial year 2022-23. 3) To invest in 20% of total capital of Vitaanova Healthcare Uganda Limited, a Uganda based Pharmaceutical Company. 4) Any other business as Board deem fit to discuss, with the permission of the Chair.